This study investigates the cardioprotective activity of a combined treatment of Ginkgo biloba phytosomes (GBP) and Ocimum sanctum extract (Os) in isoproterenol (ISO)-induced myocardial necrosis in rats. Significant myocardial necrosis, depletion of the endogenous antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR), and glutathione (GSH), and increases in the serum marker enzymes aspartate aminotransferase (AST), lactate dehydrogenase (LDH), and creatine phosphokinase (CPK) were observed in ISO-treated rats compared with normal rats. Co-administration of GBP (100 mg per kg) with Os at two doses (50 and 75 mg per kg) for 30 days to rats treated with ISO (85 mg per kg, sc) on the 29th and 30th days demonstrated a significant decrease in ISO-induced serum marker enzyme elevations and a significant attenuation of the ISO-elevated myocardial lipid peroxidation marker malondialdehyde (MDA). A significant restoration of ISO-depleted activities and levels of AST, LDH, CPK, GSH, SOD, CAT, GPx, and GR in the hearts of the treatment groups was observed. The combination of Os 75 mg per kg and GBP 100 mg/kg elicited greater protection than the combination of Os 50 mg per kg and GBP 100 mg per kg. It may be concluded that GBP-Os oral treatment to ISO-challenged rats demonstrates significant cardiac protection, decreases lipid peroxidation, and restores antioxidant activities. However, the combined treatment failed to enhance cardioprotective activity of either herb when used alone.
Download full-text PDF |
Source |
---|
J Cell Mol Med
March 2025
Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, P.R. China.
Cardiac remodelling, a pathological process induced by various cardiovascular diseases, remains a significant challenge in clinical practice. Here, we investigate the potential of Danuglipron (PF-06882961, PF), a novel oral glucagon-like peptide-1 (GLP-1) receptor agonist, in alleviating pressure overload (PO)-induced cardiac hypertrophy and fibrosis. Using both in vivo and in vitro models, we demonstrate that PF treatment (1 mg/kg/day, orally for 8 weeks) significantly attenuates aortic banding-induced cardiac dysfunction and pathological remodelling in mice.
View Article and Find Full Text PDFProc Natl Acad Sci U S A
March 2025
Department of Biomedical Sciences, University of Padova, Padova 35131, Italy.
Regulation of mitochondrial Ca uptake is critical in cardiac adaptation to chronic stressors. Abnormalities in Ca handling, including mitochondrial uptake mechanisms, have been implicated in pathological heart hypertrophy. Enhancing mitochondrial Ca uniporter (MCU) expression has been suggested to interfere with maladaptive development of heart failure.
View Article and Find Full Text PDFNaunyn Schmiedebergs Arch Pharmacol
March 2025
Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Malaya University, Kuala Lumpur, Malaysia.
Vitamin B6 (pyridoxine) vitamins are of interest in preventative and protective strategies in cardiovascular disease. However, the safety and efficacy of vitamin B6 has been questioned. The aim of this study was to study the protective effect of pyridoxine, amlodipine, and their combination against vasopressin-induced angina model in rats.
View Article and Find Full Text PDFIran J Pharm Res
December 2024
Department of Clinical Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Background: Atherosclerosis remains the leading cause of mortality worldwide, highlighting the urgent need for innovative treatments targeting chronic inflammation. Recent research indicates that quercetin (QCT) and curcumin, two naturally occurring compounds, have potential therapeutic benefits in cardiovascular diseases.
Objectives: This study focuses on the novel synthesis of nano-quercetin (N-QCT) encapsulated in solid lipid nanoparticles (SLNs) and investigates the synergistic cardioprotective effects of N-QCT and curcumin on human vascular smooth muscle cells (VSMCs).
J Transl Med
March 2025
Department of Geriatrics, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
Background: In developed nations, myocardial infarction (MI) is one of the main causes of morbidity and mortality, resulting in a significant economic burden and becoming a global public health problem. C1q/tumor necrosis factor-related protein 9 (CTRP9) is a secreted protein comprising a variable domain, a collagenous region, and a C-terminal trimerizing globular C1q (gC1q) domain. In vivo, the full-length CTRP9 (fCTRP9) can be cleaved into the globular domain of CTRP9 (gCTRP9).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!